Literature DB >> 19787821

The pH sensitivity of histidine-containing lytic peptides.

Zhigang Tu1, Albert Young, Christopher Murphy, Jun F Liang.   

Abstract

Many bioactive peptides are featured by their unique amino acid compositions such as argine/lysine-rich peptides. However, histidine-rich bioactive peptides are hardly found. In this study, histidine-containing peptides were constructed by selectively replacing the corresponded lysine residues in a lytic peptide LL-1 with histidines. Interestingly, all resulting peptides demonstrated pH-dependent activities. The cell lysis activities of these peptides could be increased up to four times as the solution pHs dropped from pH = 7.4 to pH = 5.5. The pH sensitivity of a histidine-containing peptide was determined by histidine substitution numbers. Peptide derivatives with more histidines were associated with increased pH sensitivity. Results showed that not the secondary structures but pH-affected cell affinity changes were responsible for the pH-dependent activities of histidine-containing peptides. The histidine substitution approach demonstrated here may present a general strategy to construct bioactive peptides with desired pH sensitivity for various applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19787821      PMCID: PMC3025445          DOI: 10.1002/psc.1180

Source DB:  PubMed          Journal:  J Pept Sci        ISSN: 1075-2617            Impact factor:   1.905


  23 in total

1.  Antitumour activity and specificity as a function of substitutions in the lipophilic sector of helical lactoferrin-derived peptide.

Authors:  Nannan Yang; Tore Lejon; Oystein Rekdal
Journal:  J Pept Sci       Date:  2003-05       Impact factor: 1.905

Review 2.  Experimentally determined hydrophobicity scale for proteins at membrane interfaces.

Authors:  W C Wimley; S H White
Journal:  Nat Struct Biol       Date:  1996-10

3.  IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature and symbolism for amino acids and peptides. Recommendations 1983.

Authors: 
Journal:  Eur J Biochem       Date:  1984-01-02

4.  In vitro activities of native and designed peptide antibiotics against drug sensitive and resistant tumor cell lines.

Authors:  Sunkyu Kim; Sukwon S Kim; Yung Jue Bang; Seong Jin Kim; Byeong Jae Lee
Journal:  Peptides       Date:  2003-07       Impact factor: 3.750

5.  Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranes.

Authors:  E Terzi; G Hölzemann; J Seelig
Journal:  Biochemistry       Date:  1997-12-02       Impact factor: 3.162

6.  Interactions of histatin 5 and histatin 5-derived peptides with liposome membranes: surface effects, translocation and permeabilization.

Authors:  Alice L Den Hertog; Harro W Wong Fong Sang; Ruud Kraayenhof; Jan G M Bolscher; Wim Van't Hof; Enno C I Veerman; Arie V Nieuw Amerongen
Journal:  Biochem J       Date:  2004-05-01       Impact factor: 3.857

7.  Detection of in vivo lipid peroxidation using the thiobarbituric acid assay for lipid hydroperoxides.

Authors:  D T Kirkpatrick; D J Guth; R D Mavis
Journal:  J Biochem Toxicol       Date:  1986-03

8.  Clavanin permeabilizes target membranes via two distinctly different pH-dependent mechanisms.

Authors:  Ellen J M van Kan; Rudy A Demel; Eefjan Breukink; Arie van der Bent; Ben de Kruijff
Journal:  Biochemistry       Date:  2002-06-18       Impact factor: 3.162

Review 9.  Targeted cancer therapeutics.

Authors:  William N Hait; Trevor W Hambley
Journal:  Cancer Res       Date:  2009-02-10       Impact factor: 12.701

10.  Extracellular pH distribution in human tumours.

Authors:  K Engin; D B Leeper; J R Cater; A J Thistlethwaite; L Tupchong; J D McFarlane
Journal:  Int J Hyperthermia       Date:  1995 Mar-Apr       Impact factor: 3.914

View more
  8 in total

1.  The activity of a small lytic peptide PTP-7 on Staphylococcus aureus biofilms.

Authors:  Riddhi Kharidia; Jun F Liang
Journal:  J Microbiol       Date:  2011-09-02       Impact factor: 3.422

2.  The potential roles of cell surface pHs in bioactive peptide activation.

Authors:  Long Chen; Jun F Liang
Journal:  Chem Biol Drug Des       Date:  2014-07-07       Impact factor: 2.817

3.  Metabolic monosaccharides altered cell responses to anticancer drugs.

Authors:  Long Chen; Jun F Liang
Journal:  Eur J Pharm Biopharm       Date:  2012-04-02       Impact factor: 5.571

4.  The Effects of Metal Ions on the Cytotoxicity and Selectivity of a Histidine-Containing Lytic Peptide.

Authors:  Long Chen; Sijia Dong; Jun F Liang
Journal:  Int J Pept Res Ther       Date:  2013-02-24       Impact factor: 2.191

5.  Efficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse model.

Authors:  Jayaram Lakshmaiah Narayana; Han-Ning Huang; Chang-Jer Wu; Jyh-Yih Chen
Journal:  Oncotarget       Date:  2015-05-30

6.  Design and pharmacodynamics of recombinant NZ2114 histidine mutants with improved activity against methicillin-resistant Staphylococcus aureus.

Authors:  Huixian Chen; Ruoyu Mao; Da Teng; Xiumin Wang; Ya Hao; Xingjun Feng; Jianhua Wang
Journal:  AMB Express       Date:  2017-02-22       Impact factor: 3.298

7.  Improving the anticancer effect of afatinib and microRNA by using lipid polymeric nanoparticles conjugated with dual pH-responsive and targeting peptides.

Authors:  Shu-Ting Hong; Huaching Lin; Chen-Shen Wang; Chih-Hsien Chang; Anya Maan-Yuh Lin; James Chih-Hsin Yang; Yu-Li Lo
Journal:  J Nanobiotechnology       Date:  2019-08-19       Impact factor: 10.435

Review 8.  Overcoming the cellular barriers and beyond: Recent progress on cell penetrating peptide modified nanomedicine in combating physiological and pathological barriers.

Authors:  Yingke Liu; Zhihe Zhao; Man Li
Journal:  Asian J Pharm Sci       Date:  2022-06-23       Impact factor: 9.273

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.